Fig. 6From: Design, synthesis, and biological evaluation of chalcones for anticancer properties targeting glycogen synthase kinase 3 betaCompound 14 suppresses stemness potentials of MCF-7SC cells. A, B CD44 + /CD24 − populations were measured by FACS analysis following compound 14 treatment for 24 h. Quantification of CD44 + /CD24 − population normalized to control. C, D Expression of stemness markers was detected by western blotting following treatment with compound 14 for 24 h. β –actin was used as a loading controlBack to article page